Sharmila Dissanaike Heron Therapeutics, Inc. (HRTX) insider trading activity

HRTX Quotes by TradingView

Sharmila Dissanaike is Director of HERON THERAPEUTICS, INC. . Currently has a direct ownership of 69,230 shares of HRTX, which is worth approximately $80,999. The most recent transaction as insider was on Jan 19, 2024, when has been sold 13,948 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 69.2K
0% 3M change
25.23% 12M change
Total Value Held $80,999

Sharmila Dissanaike Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 19 2024
BUY
Grant, award, or other acquisition
-
13,948 Added 16.77%
69,230 Common Stock
Dec 16 2022
BUY
Grant, award, or other acquisition
-
38,580 Added 41.1%
55,282 Common Stock
Dec 22 2021
BUY
Grant, award, or other acquisition
-
10,452 Added 38.49%
16,702 Common Stock
SD

Sharmila Dissanaike

Director
San Diego, CA

Track Institutional and Insider Activities on HRTX

Follow HERON THERAPEUTICS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HRTX shares.

Notify only if

Insider Trading

Get notified when an Heron Therapeutics, Inc. insider buys or sells HRTX shares.

Notify only if

News

Receive news related to HERON THERAPEUTICS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on HRTX